Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$0.36 - $0.49 $14,167 - $19,282
-39,353 Reduced 10.97%
319,516 $119,000
Q3 2022

Nov 14, 2022

BUY
$0.45 - $0.69 $79,834 - $122,412
177,410 Added 97.77%
358,869 $179,000
Q2 2022

Aug 15, 2022

BUY
$0.42 - $0.78 $76,212 - $141,538
181,459 New
181,459 $106,000
Q1 2022

May 16, 2022

SELL
$0.7 - $1.51 $100,094 - $215,917
-142,992 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$1.16 - $2.23 $311,716 - $599,247
-268,721 Reduced 65.27%
142,992 $189,000
Q3 2021

Nov 15, 2021

BUY
$2.24 - $4.29 $872,121 - $1.67 Million
389,340 Added 1740.22%
411,713 $947,000
Q2 2021

Aug 16, 2021

SELL
$4.39 - $7.23 $1.23 Million - $2.03 Million
-281,151 Reduced 92.63%
22,373 $98,000
Q1 2021

May 17, 2021

BUY
$4.39 - $9.08 $677,649 - $1.4 Million
154,362 Added 103.49%
303,524 $2.2 Million
Q4 2020

Feb 16, 2021

SELL
$3.86 - $5.07 $825,406 - $1.08 Million
-213,836 Reduced 58.91%
149,162 $644,000
Q3 2020

Nov 16, 2020

BUY
$4.11 - $6.45 $587,586 - $922,124
142,965 Added 64.97%
362,998 $1.49 Million
Q2 2020

Aug 14, 2020

BUY
$5.75 - $11.99 $1.27 Million - $2.64 Million
220,033 New
220,033 $1.32 Million
Q1 2020

May 14, 2020

SELL
$5.65 - $15.71 $440,242 - $1.22 Million
-77,919 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$10.15 - $15.58 $3.1 Million - $4.76 Million
-305,479 Reduced 79.68%
77,919 $1.07 Million
Q3 2019

Nov 14, 2019

SELL
$11.88 - $16.72 $810,643 - $1.14 Million
-68,236 Reduced 15.11%
383,398 $4.55 Million
Q2 2019

Aug 15, 2019

BUY
$13.2 - $20.63 $5.78 Million - $9.04 Million
438,130 Added 3244.45%
451,634 $6.32 Million
Q2 2019

Aug 14, 2019

SELL
$13.2 - $20.63 $3.44 Million - $5.38 Million
-260,707 Reduced 95.08%
13,504 $3.64 Million
Q1 2019

May 14, 2019

SELL
$12.01 - $19.49 $183,981 - $298,567
-15,319 Reduced 5.29%
274,211 $4.9 Million
Q4 2018

Feb 14, 2019

BUY
$12.4 - $18.7 $3.59 Million - $5.41 Million
289,530 New
289,530 $4.55 Million

Others Institutions Holding ORTX

About Orchard Therapeutics plc


  • Ticker ORTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,458,000
  • Description
  • Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...
More about ORTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.